StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) income statement

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$6.14+0.45 (+7.91%)

Close on Nov 18, 2026Market cap $39.98MP/E –Yield –

Tevogen Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
352.5%

Financial strength

Current ratio
0.33
Debt to equity
–
Debt to assets
–
Cash to current liabilities
17.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?